Director, Global Value Evidence Strategy, Nephrology & Immunology
The Director leads global value evidence strategy for nephrology and immunology assets, coordinating health technology and value evidence input into clinical development programs. They are responsible for generating evidence to support market access, reimbursement, and patient access objectives while leading the Value Evidence Sub-Committee.